| Authors: |
Verheijden RJ; Rik J. Verheijden, MSc, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Jolien S. de Groot, MD, PhD, Babs O. Fabriek, PhD, and Miki N. Hew, MD, PhD, Medicines Evaluation Board, Utrecht, the Netherlands; Anne M. May, PhD, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; and Karijn P.M. Suijkerbuijk, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., de Groot JS; Rik J. Verheijden, MSc, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Jolien S. de Groot, MD, PhD, Babs O. Fabriek, PhD, and Miki N. Hew, MD, PhD, Medicines Evaluation Board, Utrecht, the Netherlands; Anne M. May, PhD, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; and Karijn P.M. Suijkerbuijk, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Fabriek BO; Rik J. Verheijden, MSc, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Jolien S. de Groot, MD, PhD, Babs O. Fabriek, PhD, and Miki N. Hew, MD, PhD, Medicines Evaluation Board, Utrecht, the Netherlands; Anne M. May, PhD, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; and Karijn P.M. Suijkerbuijk, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hew MN; Rik J. Verheijden, MSc, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Jolien S. de Groot, MD, PhD, Babs O. Fabriek, PhD, and Miki N. Hew, MD, PhD, Medicines Evaluation Board, Utrecht, the Netherlands; Anne M. May, PhD, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; and Karijn P.M. Suijkerbuijk, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., May AM; Rik J. Verheijden, MSc, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Jolien S. de Groot, MD, PhD, Babs O. Fabriek, PhD, and Miki N. Hew, MD, PhD, Medicines Evaluation Board, Utrecht, the Netherlands; Anne M. May, PhD, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; and Karijn P.M. Suijkerbuijk, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Suijkerbuijk KPM; Rik J. Verheijden, MSc, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Jolien S. de Groot, MD, PhD, Babs O. Fabriek, PhD, and Miki N. Hew, MD, PhD, Medicines Evaluation Board, Utrecht, the Netherlands; Anne M. May, PhD, Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; and Karijn P.M. Suijkerbuijk, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. |
